Subcommittee E56.08 on Nano-Enabled Medical Products

Matching Standards Under the Jurisdiction of E56.08 by Status

Proposed New

  • WK69051 Assessing the Activation of the Complement System in Human Plasma Through Quantification of iC3b Concentration by ELISA,

  • WK67980 Quantifying Poly(ethylene glycol) Coating on the Surface of Gold Nanostructured Materials Using High Performance Liquid Chromatography with Evaporative Light Scattering Detection (HPLC/ELSD)

  • WK75607 Characterization of Encapsulation, Extraction, and Analysis of RNA in Lipid Nanoparticle Formulations for Drug Delivery

  • WK60553 Evaluating Impact of Particles and Other Materials on Phagocytic Function In Vitro

  • WK86056 Measuring In Vitro Drug Release from Liposomal Drug Formulations.

  • WK86057 New Standard Test Method for Measuring Sulfate and Ammonium Ion Concentrations in Liposome Drug Formulations

Withdrawn, Replaced